Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.

Shi L. et al, (2019), Alzheimers Dement, 15, 1478 - 1488

CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice.

Mancuso R. et al, (2019), Brain, 142, 3243 - 3264

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease.

Winchester LM. et al, (2018), Genome Med, 10

Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank.

Nevado-Holgado AJ. et al, (2016), BMJ Open, 6

Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.

Haider S. et al, (2016), Genome biology, 17, 140 - 140

Genomic alterations underlie a pan-cancer metabolic transcriptome shift

Haider S. et al, (2015), CANCER RESEARCH, 75

Include forthcoming?